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The formation of vascular lumens by endothelial cells is a critical step in the angiogenic process that occurs
during invasion and growth of the incipient vascular sprout. Once a lumen is established, capillaries are
rapidly exposed to the physical forces associated with the flow of blood which, together with genetic infor-
mation, regulate the ultimate size of inner vessel diameter. Here we review the recent literature on vascular
lumen formation and compare it to lumen formation in other epithelial systems. We also discuss the regula-
tion of lumen diameter after vascular morphogenesis has been completed.Introduction
The organization of the vascular tree requires coordinated inter-
play of genetic, microenvironmental, and epigenic factors. The
final outcome is a network of hierarchical interconnected tubules
that efficiently perfuses tissues, with the strength to absorb the
flow and pressure produced by cardiac contractions and yet
the flexibility to adapt to specific homeostatic needs. As our
understanding of the processes that regulate the emergence
and differentiation of blood vessels improves, the attention of
the field is shifting to questions associated with more complex
aspects of the assembly of 3D vascular structures. For example,
how do blood vessels remodel into hierarchical structures that
are able to regulate blood pressure and control efficient perfu-
sion of tissues? How do cell-cell interactions convey organ-
specific differences to the endothelium and impact the structure
of capillaries? How is the vascular tree able to adapt and
respond to the distinct physiological needs of individual organs,
and how is this affected in disease states? Many of these ques-
tions require a sophisticated understanding of how the lumens of
endothelial cell (EC) tubular networks are formed andmaintained
and how they are regulated in embryonic versus adult tissues.
Our current understanding of how lumens originate in blood
vessels is modest, but evolving rapidly. A major challenge is
the difficulty of establishing appropriate models, systems, and
technology in vitro and in vivo to enable molecular dissection
of these events. A number of in vitro models have now been
used to elucidate molecular requirements for EC lumen and
tubule formation in 3D extracellular matrix (ECM) environments
(Aplin et al., 2008; Davis et al., 2007; Davis and Senger, 2005;
Holderfield and Hughes, 2008; Koh et al., 2008b; Nakatsu and
Hughes, 2008). One of the challenges we face in this analysis
is dissociating the early sprouting process from lumen formation,
as they occur concurrently. Unlike epithelial cells, ECs form
lumens as they invade tissues. In addition, their squamous shape
and their relative lack of specific apical/basolateral markers have
made it extremely difficult to address mechanistic questions of
lumen formation in vivo. Like epithelial lumen formation (Bryant
and Mostov, 2008; Levi et al., 2006; Lubarsky and Krasnow,222 Developmental Cell 16, February 17, 2009 ª2009 Elsevier Inc.2003; Martin-Belmonte and Mostov, 2007), the morphogenesis
of tubes in vascular structures requires the coordinated partici-
pation of multiple molecules including small GTPases, cell
surface receptors, and cell-matrix and cell-cell adhesion
proteins (Adams and Alitalo, 2007; Avraamides et al., 2008; Baz-
zoni and Dejana, 2004; Davis et al., 2007; Dejana, 2004; Dejana
et al., 2009; Horowitz and Simons, 2008; Koh et al., 2008a)
(Figure 1). However, in contrast to epithelial biology, progress
in understanding vascular lumen formation has not been able
to benefit significantly from genetic screens in Drosophila.
Finally, although some of the aspects of lumen formation seem
to be conserved between epithelium and endothelium, the
emerging details about molecular players and regulatory mech-
anisms suggest that there are also important differences.
The process of lumen formation is extremely efficient and it
enables ECs to immediately cope with physical forces imposed
by shear stress, as well as a complex combination of intermit-
tent, laminar, and turbulent flow patterns. During this process,
homotypic cell-cell interactions are ready to withstand these
physical forces initially in the absence of additional support
from mural cells. Although the diameter of vessels appears
to be determined genetically, it has been demonstrated that
flow is essential for maintenance and regulation of lumen diam-
eter (Jones et al., 2006). Some of the genetic regulators of
vascular lumen size are emerging through serendipitous findings
from mammalian genetic models, but the interplay between
genetics and mechanotransduction has yet to be explored in
detail.
The inner diameter of vessels impacts blood pressure and
therefore perfusion of both nutrients and the blood cells that
control oxygen delivery and immunological surveillance. Many
of the factors that influence EC luminal integrity, or patency,
have a broad functional impact. Thus, understanding the control
and maintenance of lumen size and the factors that regulate
lumen diameter is of high pathophysiological relevance. Here,
we have compiled current knowledge on the molecular process
of lumen formation by ECs and the regulatory mechanisms that
establish, and later maintain, the inner diameter of blood vessels.
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The morphogenesis of lumens in ECs occurs concomitantly with the invasion of vascular sprouts. Either as single or multiple cellular aggregates, the first cellular
indication of lumen formation is the presence of large intracellular vesicles (left panel). Upon fusion, the vesicles form an incipient lumen (central panel) that aligns
with the patent circulation. Molecular requirements for these events include the activity of integrins, Cdc42 and Rac, in addition to Pak2, Pak4, and the polarity
complex Par3/Par6/PKCz. The activity of proteinases, in particular MT1-MMP, is also required.Cellular Mechanisms Underlying Vascular
Lumen Formation
In an important conceptual review a few years ago, Lubarsky and
Krasnow described five potential mechanisms by which epithe-
lial cells could form lumens and tubular structures during
morphogenetic processes (Lubarsky and Krasnow, 2003). These
were (1) wrapping, whereby a planar cell sheet wraps to form
a tube; (2) budding, where a sprout emanates from a pre-existing
tube; (3) cavitation, where a space is created by elimination of
centrally placed cells in a cell-cell aggregated sphere or cylinder;
(4) cord hollowing, in which a cord or cylinder of packed cells
creates a central space by cell shape changes, such as flattening
of cells along the wall of the cylinder; and (5) cell hollowing,
whereby individual cells create intracellular spaces within them
to generate a lumenal structure. Considerable work by a number
of laboratories suggests that three of these mechanisms,
budding, cord hollowing, and cell hollowing, operate in vascular
ECs during developmental or postnatal angiogenic events
(Adams and Alitalo, 2007; Davis et al., 2002, 2007; Davis and
Senger, 2005; Egginton and Gerritsen, 2003; Holderfield and
Hughes, 2008). In our view, the budding and cord hollowing
mechanisms may be essentially synonymous in the context of
angiogenic sprouting. Leading EC tip cells (Gerhardt et al.,
2003) invade matrices, creating spaces that can be occupied
transiently by a cord of trailing cells without an apparent lumen,
but in other instances the lumen becomes more immediately
apparent in the trailing trunk cells (Bayless and Davis, 2003;
Davis et al., 2007; Gerhardt et al., 2003; Holderfield and Hughes,
2008; Saunders et al., 2006). Despite these temporal distinc-
tions, there is a common underlying process in which trunk
ECs flatten onto the wall of a matrix space created by the lead
invasive cell, initiating a lumenal area and leading to a tube that
develops from the trailing cells. To illustrate these events, we
have included EC tube morphogenic movies in 3D collagen
matrices in which invading EC tip cells lead invasion followed
by the appearance of EC lumenal structures (see Movies
S1–S3 available online). These movies illustrate that vessel
morphogenesis is a highly dynamic process in which invasion,
motility, and lumenogenesis occur concurrently in different
vessels or different regions of the developing tube.
By contrast, cell hollowing, or intracellular vacuolation, is
a mechanism by which individual cells generate vesicles that,after exocytic events, enable the cells to interconnect with neigh-
bors to form multicellular lumens and tubes (Figure 1, Movie S4)
(Bayless and Davis, 2002; Bayless et al., 2000; Davis and Bay-
less, 2003; Davis et al., 2007; Egginton and Gerritsen, 2003;
Folkman and Haudenschild, 1980; Kamei et al., 2006; Koh
et al., 2008a). The intracellular vacuolation mechanism has
been most frequently observed when single ECs are initiating
morphogenesis in a situation where they do not have contact
with adjacent cells, as occurs during vasculogenesis in a 3D
environment (Adams and Alitalo, 2007; Drake, 2003; Risau and
Flamme, 1995). The intracellular vacuolation process is also
extremely dynamic and it is a rapid way to create EC lumenal
spaces, as observed in vitro and in vivo (Bayless and Davis,
2002; Bayless et al., 2000; Davis and Camarillo, 1996; Kamei
et al., 2006; Koh et al., 2008a). Intracellular vacuolation is also
noted in matrix invasion assays from monolayers (Movies S2
and S3) in which ECs are associated with neighboring cells, so
it is not restricted to individual ECs. As intracellular vacuoles
have been demonstrated in vivo in many cell types that make
lumenal structures (in both epithelial and endothelial cells), and
since single cells can make lumens in vivo and in vitro (Bagnat
et al., 2007; Davis and Bayless, 2003; Lubarsky and Krasnow,
2003), it is clear that this mechanism plays a role during tubulo-
genesis. In Movie S5, EC lumens appear to form primarily by
EC flattening against a pre-existing matrix space, and lumen
expansion is most likely propelled by continuous membrane-
bound matrix metalloproteinase (MMP)-dependent proteolysis
(Davis et al., 2007; Saunders et al., 2006). In this case, intracel-
lular vacuoles are much less prominent. We believe it likely that
the different mechanisms discussed above occur in a context-
dependent manner, but in many instances they might also occur
concurrently (see Movies S1–S5).
A common feature of all these different mechanisms is that the
ECs create physical spaces within the 3D ECM via surface-
located proteolysis as they form lumen and tube networks (Davis
et al., 2007). ECs can flatten and assume the characteristic
cobblestone appearance along the wall of these spaces through
EC-matrix contacts and then connect with adjacent cells
through intercellular junctional adhesions (Bazzoni and Dejana,
2004). Thus, in many respects these potentially distinct initiating
mechanisms are likely to have common molecular and signal
transduction requirements. For example, ECs seeded as singleDevelopmental Cell 16, February 17, 2009 ª2009 Elsevier Inc. 223
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in 3D collagen matrices (Davis and Saunders, 2006). Similarly,
membrane MMPs such as MT1-MMP are required for ECs to
sprout and form tube structures from either an EC monolayer
surface or an intact tissue such as an aortic ring (Chun et al.,
2004; Lafleur et al., 2002; Saunders et al., 2006). In some
instances invading cells appear to organize cord-like structures
first and only subsequently lumenize, while on other occasions
the lumen is observed earlier just following the advancing tip cell.
Signaling Mechanisms Controlling Formation of EC
Lumens and Tubes
Most of our current understanding of signaling processes during
EC lumen formation has come from analyses in culture using
3D ECM environments, with some supporting evidence from
zebrafish and knockout mice. These analyses have shown that
integrin-ECM interactions play a critical functional role during
vascular morphogenesis to regulate sprouting, lumenogenesis,
and tube stabilization (Avraamides et al., 2008; Davis and Sen-
ger, 2005; Mahabeleshwar and Byzova, 2008; Rupp and Little,
2001; Stupack and Cheresh, 2004). Substantial evidence
suggests that several integrins and ECM proteins play unique
roles during these events. For example, collagen (Davis and Sen-
ger, 2005), fibrin-fibronectin (Holderfield and Hughes, 2008), and
fibronectin-rich embryonic matrices (Astrof et al., 2007; Hynes,
2007) represent promorphogenic environments, whereas base-
ment membrane proteins appear to be inhibitory or nonpermis-
sive for vascular morphogenesis (Davis and Senger, 2005,
2008). Pharmacological blockade of b1 integrin using antibodies
resulted in complete absence of lumens in the aorta of chicken
embryos (Drake et al., 1992). In addition to the contribution
of the b1 family of integrins (a2b1, a1b1, a5b1, and a4b1), the
av integrins, avb3 and avb5, which recognize promorphogenic
matrices, have also been shown to influence lumen formation
in vitro (Figure 1) (Bayless et al., 2000; Calzada et al., 2004; Davis
and Camarillo, 1996; Davis and Senger, 2005; Hood et al., 2003;
Senger et al., 1997).
Downstream of integrin signaling, activation of Src and FAK
kinases contributes to the process of lumen formation. A number
of studies demonstrate essential roles for these kinases in early
tube morphogenic events and tube stabilization (Eliceiri et al.,
2002; Ilic et al., 2003; Im and Kazlauskas, 2007; Liu and Senger,
2004). EC-specific knockouts of FAK show embryonic lethality,
and global FAK knockouts in mice reveal vascularization defects
as well (Shen et al., 2005). Interestingly, early vasculogenic
events were not disrupted in EC-specific FAK knockouts, while
later events associated with tube stabilization appeared to be
defective. A recent study shows that Pyk2, a FAK-related kinase,
can compensate for EC-specific FAK knockout in adult mice
(Weis et al., 2008). Thus, it appears that a combination of FAKand
Pyk2 downstream of integrin signaling can regulate EC morpho-
genesis, and probably stabilization.
Integrin signaling also activates Rho GTPases, which regulate
endothelial cytoskeleton and tubemorphogenic responses (Bay-
less and Davis, 2002; Bryan and D’Amore, 2007; Connolly et al.,
2002; Davis and Bayless, 2003; Hoang et al., 2004; Kiosses et al.,
2002; Koh et al., 2008a). The first reports indicating a role for Rho
GTPases in EC morphogenesis revealed the involvement of
Cdc42 and Rac1 during these events (Bayless and Davis, 2002;224 Developmental Cell 16, February 17, 2009 ª2009 Elsevier Inc.Connolly et al., 2002; Kiosses et al., 2002). Cdc42 was shown
to be a critical regulator of EC lumen formation along with Rac1
by expressing dominant-negative mutants of these GTPases
(Bayless and Davis, 2002), and also, more recently by an siRNA
approach (Koh et al., 2008a). EC-specific knockout of Rac1 or
one of its downstream effectors, Wave2, leads to defects in
vascular development, suggesting their involvement during these
events in vivo (Tan et al., 2008; Yamazaki et al., 2003). Previous
studies have shown that intracellular vacuole formation and coa-
lescence occurs within ECs in vitro and that the intracellular
vacuole compartment can be labeled by extracellular
membrane-impermeant dyes, demonstrating that it arises via
pinocytic events (Davis and Camarillo, 1996). To some extent,
the EC intracellular vacuole formation and coalescence process
resembles the process ofmacropinocytosis, which is alsoCdc42
and Rac1 dependent. Both processes also require functional
actin and microtubule cytoskeletons (Bayless and Davis, 2002;
Davis and Bayless, 2003; Davis et al., 2007).
GFP-Rac1 and GFP-Cdc42 target vesicles to the intracellular
vacuole compartment that controls EC lumen formation in vitro
(Bayless and Davis, 2002). Similarly, GFP-Cdc42 labels intracel-
lular vacuoles in ECs in vivo as shown by time-lapse imaging in
zebrafish embryos. These vacuoles were found to uptake dye
delivered by intravascular injection (Kamei et al., 2006). The
findings suggest that this initially enclosed membrane space
fuses with the developing luminal surface in individual cells
through exocytosis, creating a lumen compartment. When this
occurs in adjacent ECs, multicellular tubular structures form
and assemble (see Movie S4) (Kamei et al., 2006).
An alternative view is that lumen formation initially requires
cell-cell interactions mediated via junctional contacts between
ECs (Blum et al., 2008). It is certainly possible, and actually quite
likely, that multiple mechanisms contribute to lumen formation
and expansion, as we discuss above. In fact, and as it will be
discussed below in detail, the formation of lumens by the
Drosophila endocardium suggests yet another distinct form of
lumen formation that requires the redistribution of cadherins
under the regulatory control of Slit-Robo (Medioni et al., 2008;
Santiago-Martinez et al., 2008).
Downstream Effectors of Small GTPases in EC Lumen
and Tube Morphogenesis
Rho GTPases such as Cdc42 and Rac1, in their GTP-bound
form, bind effectors to influence signal transduction and modu-
late the actin and microtubule cytoskeletons. For example,
Rac1 is known to activate p21-activated kinases (Paks), which
influences EC tube morphogenesis (Kiosses et al., 2002; Koh
et al., 2008a). In a recent study, both Pak2 (activated by both
Rac1 and Cdc42) and Pak4 (selectively activated by Cdc42)
were found to be required for ECs to form lumens and tubes
in 3D collagen matrices (Koh et al., 2008a). These data were
obtained using dominant-negative inhibitors of both kinases
plus siRNA suppression of both genes, which strongly blocks
EC lumenogenesis. The activation of these two kinases parallels
the activation of Cdc42 and Rac1 during these events and
directly correlates with the lumen formation process (Figure 1).
Interestingly, their activation is strongly stimulated by protein
kinase C (PKC) activation (which also stimulates EC lumen
formation), particularly the novel PKC isoform PKC3 (Koh et al.,
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use of pharmacologic inhibitors markedly attenuates the Pak2-
and Pak4-dependent EC lumen formation response. The study
also showed that Cdc42 forms a complex with activated Pak2
and Pak4 during the acquisition of patency by ECs, and that
the polarity regulator Par3 was also part of the multiprotein
complex (Koh et al., 2008a). Thus, in this signaling pathway
downstream of integrin-ECM interactions, Cdc42 and Rac1 acti-
vate Pak kinases which, in conjunction with polarity proteins,
controls lumen formation in incipient endothelial tubes (Koh
et al., 2008a). It is likely that this signaling also controls the posi-
tioning of intracellular vacuoles and the organization of a lumen
compartment within individual ECs to facilitate proper orienta-
tion and coordinate a multicellular tubular structure.
Recent studies also implicate cerebral cavernous malforma-
tion signaling proteins (e.g., CCM2) in the regulation of lumen
formation and maintenance during mouse and zebrafish
embryogenesis (Kleaveland et al., 2009; Whitehead et al.,
2009). Underlying mechanisms controlling these phenomena
include the ability of CCM2 to affect small GTPase signaling
involving Rho and Rap GTPases. siRNA suppression of CCM2
in human ECs blocks lumen formation, as well as EC sprouting
in vitro, which correlates with the inability of particular vessels
to become patent following EC-specific knockout of CCM2
in vivo (Kleaveland et al., 2009; Whitehead et al., 2009).
Contribution of MMPs to Lumen Formation
ECM degradation is necessary to form lumen and tube struc-
tures in either 3D collagen or fibrin matrices (Davis et al., 2007;
Davis and Senger, 2005; Lafleur et al., 2002). EC sprouting
from either surface monolayers or pre-existing vascular walls
into a 3D matrix also requires proteolysis. In particular, MMPs
are necessary for these events, and the membrane-anchored
MMP MT1-MMP is a major proteinase involved in this process
(Chun et al., 2004; Saunders et al., 2006) (Figure 1). Recently, it
has been shown that MT1-MMP is required for EC lumenogene-
sis in 3D collagenmatrices and that it represents themajor target
of tissue inhibitor of metalloproteinases (TIMPs) such as TIMP-2
and TIMP-3, known to block EC morphogenic events (Saunders
et al., 2006). Interestingly, TIMP-2 from ECs and TIMP-3 from
pericytes represent an inhibitory pair of TIMPs that facilitate
tube stabilization in maturing vessels by suppressing both pro-
morphogenic and separate proregression stimuli that depend
on different subsets of MMPs (Saunders et al., 2006). An inter-
esting question that emerges from this work is how MT1-MMP
interfaces with integrin signaling through Cdc42 and Rac1 to
control the EC lumen and tube formation cascade.
A final point concerning the involvement of ECMdegradation in
EC lumen and tube formation is that physical spaces within the
matrix are created during these events. These physical spaces
have recently been termed vascular guidance tunnels and influ-
ence both EC motility and vascular remodeling in 3D matrix
spaces (Davis et al., 2007). When perturbations occur in the
patterning of vessels as a result of alterations in signaling or defi-
ciency of a given required molecule (e.g., changes in Notch
signaling), the malformed vessels will also have a coincident
alteration in the pattern and organization of the matrix tunnel
spaces that are generated during the abnormal tube morpho-
genic response. These abnormalities would also be expected inthe context of the tumor vasculature. The consequences of
such matrix alterations are not fully appreciated at the moment,
but may have profound influences in later steps of vascular
remodeling such as pericyte and/or vascular smooth muscle
recruitment, which are necessary for vascular stabilization.
Cell Polarity in EC Lumen Formation
A key characteristic of both epithelial and endothelial cell lumens
is that they possess apical/basolateral polarity with respect to
a fluid-filled lumenal compartment and ECM that is associated
with the basal surface. Maintenance of apical-basal polarity
requires cell-cell junctional contacts and cell-ECM contacts on
the basal surface (Bryant and Mostov, 2008). A fundamental
question is how cell polarity mechanisms affect the process of
EC lumenogenesis and how the ensuing events lead to the
development of patent vessels with polarized apical and baso-
lateral surfaces. These issues are just now being addressed by
investigators in the endothelial field, and there are therefore
many unanswered questions. We feel that it is important to point
out that cell polarization in epithelial cells and ECs appears to be
distinct and there is much less evidence for apical and basolat-
eral sorting of proteins in ECs. The reasons for these differences
are unclear, but they likely reflect the distinct molecular compo-
nents within the different cell types and the critical functional
differences between them, such as the exposure of ECs to blood
flow, high shear stresses, and pressures, which are initiated early
during development.
In broad terms, cell polarity is controlled by a complex series of
proteins, including the Par proteins Par6 and Par3 and atypical
PKC isoforms (such as PKCz) (Etienne-Manneville and Hall,
2003a; Joberty et al., 2000; Lin et al., 2000; Macara, 2004). Inter-
estingly, Par6 binds directly to Cdc42, aRhoGTPase required for
centrosome reorientation during directed cell migration events
(Etienne-Manneville and Hall, 2003a, 2003b). This Cdc42/Par6/
Par3/atypical PKC pathway is now thought to interact with the
tight junctional apparatus (Macara, 2004). As discussed above,
Cdc42 and the Par6/Par3/atypical PKC complex are required
for lumen formation by ECs in 3D ECMs (Bayless and Davis,
2002; Kamei et al., 2006; Koh et al., 2008a). Cadherins play an
integral role inmaintaining polarity in epithelial cells, and an asso-
ciation between Par3/Par6 and VE-cadherin in ECs has been
reported recently, although the functional role has not yet been
elucidated (Iden et al., 2006). Cell polarity in epithelial cells is
also controlled by the Discs large/Scribble/Lgl proteins and
Crumbs/PALS1/PATJ complexes, which facilitate epithelial junc-
tional contacts to further regulate apical/basolateral polarity
(Bryant and Mostov, 2008; Macara, 2004) . At this point, there is
little to no information on whether these latter proteins play any
role in EC function and polarity regulation.
Lumen Formation and the Mechanosensory Function
of the Endothelium
From an early point, a developing vascular lumen has to with-
stand a large variety of physical forces generated by circulating
plasma and blood cells. In all vertebrates, the initiation of
heart beating precedes the completion of vascular remodeling
events; thus, developing endothelial tubes must be sufficiently
stable to sustain pressure, shear stress, and flow forces. These
forces generate remarkable changes in cell morphology andDevelopmental Cell 16, February 17, 2009 ª2009 Elsevier Inc. 225
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and cell-cell junctional complexes (Alon and Ley, 2008; Garin
and Berk, 2006; Heil and Schaper, 2004). It is well known that
vessels regress when not constantly perfused and that they
enlarge when exposed to increased flow and pressure. Although
the media layer of the vessel is the most reactive in such situa-
tions, the endothelium is also significantly activated by flow
(Davies, 2008; Gimbrone, 1999) and it contributes to the alter-
ations in lumen size. Changes in fluid shear stress mediate
EC activation by first promoting cell swelling, which partially
contributes to hyperplasia. In an effort to antagonize this effect,
ECs open ion channels to mediate efflux of osmolytes and
enable the return to its normal volume (Nilius et al., 1996). Inter-
estingly, blockade of these channels inhibits collateral growth
and facilitates vascular dilation instead (Manolopoulos et al.,
2000). While much remains to be understood, the mechanosen-
sory function of the endothelium provides an important adapta-
tive response for many organs and tissues. It also underlines the
conclusion that lumen formation and its maintenance is highly
responsive to vascular flow.
Dynamic Control of Vascular Lumen Diameter
In addition to characterizing mechanisms of EC lumen and tube
formation, it is also critical to understand how vascular lumen
size is established and how this diameter is maintained. In the
case of blood vessels this is particularly important because the
inner diameter of vessels impacts blood pressure, blood flow,
and perfusion of tissues.
In the blood vasculature, maintenance of patent tubular struc-
tures is also necessary for vessel maturation, which involves the
recruitment of pericytes and vascular smooth muscle cells
(Adams and Alitalo, 2007; Armulik et al., 2005; Holderfield and
Hughes, 2008; Hughes, 2008). These cells catalyze further
remodeling events needed to form the characteristic hierarchical
artery-capillary-vein vascular circuits. The process of mural cell
recruitment is interesting in a number of respects. For example,
some data suggest that lumen and tube formation is also accom-
panied by the activation of genes and molecules that actually
promote tube regression events (Davis and Saunders, 2006).
Thus, ECs, as they progress to form tubes, may establish the
groundwork for their own subsequent regression, which could
occur unless other signals prevent it. Interestingly, recruitment
of pericytes and vascular smooth muscle cells can actually
inhibit the intrinsic tendency of tubes composed only of ECs to
regress (Armulik et al., 2005; Benjamin et al., 1998; Davis and
Senger, 2008). Molecules that are supplied by pericytes to facil-
itate vessel stabilization include angiopoietin-1, which counter-
acts EC angiopoietin-2 (Thurston, 2003; Ward and Dumont,
2002), and TIMP-3, which prevents proteolysis by MMPs,
ADAM, and ADAMTS proteases (Davis and Saunders, 2006;
Saunders et al., 2006). ADAMs and ADAMTS have multiple func-
tions, including shedding of growth factors, receptors, and cell
adhesion molecules that affect EC function (Blobel, 2005),
(Rocks et al., 2008). They have direct inhibitory effects on
vascular morphogenesis through the regulation of angiogenesis
inhibitors (Lee et al., 2005a; Vazquez et al., 1999). As pericytes
express abundant levels of TIMP-3, an endogenous inhibitor
of these proteases, pericyte recruitment along EC tubes can
suppress such activities and facilitate tube stabilization (Janssen226 Developmental Cell 16, February 17, 2009 ª2009 Elsevier Inc.et al., 2008; Saunders et al., 2006). TIMP-2 and TIMP-3 have
been reported to antagonize VEGFR2 as well (Qi et al., 2003;
Seo et al., 2003; Stetler-Stevenson, 2008), meaning that they
can also contribute to EC tube maintenance and stabilization
by preventing VEGF-induced sprouting to initiate new tube
morphogenic events.
VEGF, the master regulator of angiogenesis, has been also
shown to regulate lumen size directly. Using a knockin strategy
to investigate the specific effect of VEGFA isoforms, Ruhrberg
and colleagues found that the soluble VEGF isoform VEGF120
generated vessels of larger diameter than VEGF188. In contrast,
mice expressing only the VEGF164 isoform had capillaries of
intermediate caliber, similar to those in wild-type animals (Ruhr-
berg et al., 2002). The distinction between the isoforms depends
on their relative abilities to interact with elements of the ECM: the
longer the isoform, the greater its affinity for matrix proteins
(Harper and Bates, 2008). It is unclear how these differences
imposemolecular changes that lead to a distinct lumen diameter.
It has been postulated that bound VEGF provides a gradient that
elicits endothelial chemotactic responses, while soluble VEGF
does not facilitate the formation of gradients and consequently
does not generate directional migratory stimuli (Grunstein et al.,
2000). Along these lines, while exploring the relevance of VEGF
processing by MMPs, Lee and colleagues provided further
support for the concept of gradients and its relation to lumen
formation (Lee et al., 2005b). They found that tumors expressing
a mutant form of VEGF164 that could not be cleaved by MMPs
remained bound to thematrix, but it was able to activate VEGFR2
and induce a significant angiogenic response (Lee et al., 2005b).
The resulting capillaries displayed extremely thin lumens and
were highly branched compared with those in tumors expressing
wild-type VEGF164 (Lee et al., 2005b). In contrast, tumors
expressing the MMP-cleaved and highly soluble form of VEGF
resulted in enlarged capillaries with poor branching patterns
(Lee et al., 2005b) (Figure 2). Interestingly, MMP-cleaved VEGF
had far-reaching effects, promoting hyperplasia in preexistent
capillaries of adjacent normal tissues (Lee et al., 2005b). These
findings indicate that soluble VEGF is highly effective at inducing
endothelial proliferation, and promoting hyperplasia, tortuosity,
and increased lumen diameter (Figure 2). Past and recent work
has indicated that VEGF can promote fusion of endothelial tubes
and thereby facilitate the expansion of lumens (Bohman et al.,
2005; Drake and Little, 1995; Gentile et al., 2008; Nakatsu et al.,
2003). Although themolecular mechanisms that precipitate these
effectsare unclear, the combinedevidenceseems to indicate that
matrix-tetheredandsolubleVEGFbothsignificantly impact lumen
size of incipient and existent capillaries (Grunstein et al., 2000;
Helm et al., 2005; Lee et al., 2005b; Wirzenius et al., 2007). Inter-
estingly, lumen size in lymphatic vessels is also under the regula-
tory control of theVEGF familyof growth factors. VEGF-E, through
the stimulation of VEGFR2,mediates hyperplasia of lymphatics in
the absence of lymphatic sprouts (Wirzenius et al., 2007).
Notch is another signaling pathway shown to impact lumen
diameter (Figure 2). In particular, gain- and loss-of-function
studies have demonstrated complementary effects on lumen
size. Inactivation of both Notch1 and Notch4 resulted in embry-
onic lethality by E9.5 with reduced vascular lumens (Uyttendaele
et al., 2001). In contrast, a constitutively active form of Notch
under the regulatory control of the VEGFR2 promoter resulted
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(A) Gain- and loss-of-function studies in mice have indicated that Notch regulates the diameter of vascular lumens. Specifically, loss-of-function analysis of
Notch1 null E9.5 mouse embryos showed narrow vascular tubes. In contrast, overexpression of an activated form of Notch results in significant vascular lumen
expansion. The diagram illustrates a transverse section of mouse embryos at E9.5 to indicate the relative differences between wild-type, loss of Notch 1 expres-
sion, and gain of Notch 1 expression. NT, neural tube.
(B) Genetic studies with exclusive expression of specific VEGF isoforms, as well as tumor studies, have indicated that matrix-bound and soluble VEGF mediates
distinct modes of vascular expansion in amanner that affects the lumenal compartment. Thus, soluble VEGF (right panel) mediates expansion of existent vessels,
resulting in enlarged, hyperplastic structures. In contrast, matrix-bound VEGF elicits rapid capillary sprouts and results in increased vascular density (middle
panel) in comparison with wild-type control (left panel).in enlarged and dilated vessels (Uyttendaele et al., 2001). More
recent findings from overexpression studies using active Notch
under the control of a different promoter also supported these
initial conclusions (Carlson et al., 2005). Together the work
suggests that, at least to some extent, lumen size appears to
be under genetic control.
To maintain a tubular structure, ECs must remain adherent to
the matrix tunnel surface created during morphogenesis, and
maintain cell-cell contacts initially mediated by adherens junc-
tions,whichcontainVE-cadherinand tight junctions. Interestingly,
recent data suggest a direct relationship between VE-cadherin
cell-cell contacts and TGF-beta receptor signaling (Rudini et al.,
2008), a known regulator of both vascular development and
tube stabilization. Furthermore, the establishment of adhesion
contacts, specifically via VE-cadherin, leads to the transcriptional
changes needed to increase expression of claudin-5, an EC-
specific tight junction component, which further strengthens
cell-to-cell contacts between ECs and thus tube stability (Taddei
et al., 2008). Interestingly, this upregulation is controlled by inhibi-
tion of Foxo1 (Dejana et al., 2007), which normally suppresses
claudin-5 expression (Taddei et al., 2008). Therefore, establish-
ment of initial cell-cell contacts via cadherins provides a positive
feedback loop to reinforce the stability of the tube through the
upregulation of tight junction proteins.
The dynamic expression and distribution of cadherins is
a central component of lumen formation by epithelial cells.Recent and unexpected contributions of the Slit-Robo signaling
system have revealed its functional interaction with cadherins
during the process of heart lumen formation in Drosophila
(Medioni et al., 2008; Santiago-Martinez et al., 2008). Taken
together, these studies demonstrate that Slit and Robo, through
what appears to be an autocrine mechanism, regulate cell shape
changes and coordinate subdomains of E-cadherin expression
that ultimately result in the formation of a lumen. Loss of either
Slit or Robo either ameliorates or completely blocks lumen
formation (Medioni et al., 2008; Santiago-Martinez et al.,
2008). Absence of Robo results in an increased level and distri-
bution of E-cadherin (Medioni et al., 2008). Similarly, loss of Slit
leads to an expansion in the association of beta-catenin with the
adhesion complexes (Santiago-Martinez et al., 2008). By
contrast, overexpression of either Robo or Slit results in ectopic
lumens, most likely as a result of their mislocalization rather than
their higher expression, and deregulation of the E-cadherin-
b-catenin complex. The work was very important because it
defined new molecular mechanisms regulating polarity and
formation of lumens between juxtaposed epithelial/endothelial
layers. Taking into account recent information on the evolu-
tionary origins of both Drosophila and vertebrate hearts
(Hartenstein and Mandal, 2006), it might well be interesting to
investigate further whether the Slit-Robo signaling axis also
contributes to lumen formation in the development of the verte-
brate cardiovascular system.Developmental Cell 16, February 17, 2009 ª2009 Elsevier Inc. 227
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Because of its multiple clinical implications, questions relating to
the maintenance and stabilization of vascular lumens have
largely been explored in the context of atherosclerosis, resteno-
sis, and hypertension. However, it is likely that some of these
mechanisms are also operative during development and in
normal adult tissues. In fully differentiated multilayered vessels,
lumen diameter is largely regulated by the contractile status of
the arterial medial layer in response to pressure and flow. Phys-
iological changes in lumen diameter can be achieved by alter-
ations in eNOS or in NO levels with distinct consequences for
blood pressure (Gregg et al., 1998; Vita et al., 2008). Pharmaco-
logically, the same can be achieved by agents that regulate the
status of smooth muscle cell contraction (Katsumi et al., 2007;
Yu et al., 2005). Indeed, the endothelial layer displays a great
ability to adapt to these alterations in diameter, probably through
net changes in plasma membrane surface area via exocytosis
and endocytosis, although this is a subject that has not been
studied in great depth. In fact, many basic questions remain,
such as: how does the endothelium perceive alterations in
contractile status of the underlying arterial media to regulate its
plasma membrane surface? And/or how are physical changes
on the basal side of the endothelium transduced to achieve
vesicular fusion on the luminal side (i.e., to add luminal plasma
membrane) or vice-versa to remove luminal plasma membrane
through vesicle internalization? These questions have yet to be
addressed at a molecular level.
Sustained pathological changes in blood pressure can result
in alterations of lumen size; although the tendency of the vessel
is to always retain its original diameter, a concept better known
as ‘‘Glagov’s phenomenon’’ (Glagov et al., 1987; Korshunov
et al., 2007). The vascular wall of arteries is able to perceive pres-
sure and adapt by remodeling all components of the vessel wall.
Thus, increases in blood pressure result in endothelial, smooth
muscle, and fibroblast hyperplasia and hypertrophy in a manner
that compensates for the increase in pressure to retain the orig-
inal lumen size. This remarkable ability to retain lumen diameter
has been validated by a large number of atherosclerosis studies
and by models of vessel remodeling in several species (Bou-
touyrie et al., 1999; Chironi et al., 2003; Leidenfrost et al.,
2003; Lim et al., 1997). However, Glagov’s phenomenon only
applies for pathological alterations that impose up to 40% vessel
remodeling; more sustained or drastic changes result in reduc-
tion of lumen and chronic hypertension (Korshunov and Berk,
2003; Miyashiro et al., 1997; Ward et al., 2001).
Clearly, flow-dependent lumenal changes require the input of
multiple cell types and processes. The molecular read-outs of
sensing changes in pressure are global alterations in gene
expression that are likely coordinated by multiple transcription
factors, some of which are currently being identified (Parmar
et al., 2006). In addition, it has been recognized that additional
genetic factors are important modulators, as revealed by the
contribution of genetic background in carotid remodeling in
partial ligation models (Korshunov and Berk, 2008).
Concluding Remarks
Our understanding of vascular lumen formation is still in its
infancy. Although some of themolecules and signaling pathways
regulating these events appear to be similar to those in epithelial228 Developmental Cell 16, February 17, 2009 ª2009 Elsevier Inc.cells, it is likely that there are important features unique to the
endothelial system. While development of an extensive vascular
plexus can occur in the absence of flow both in vitro and in vivo,
indicating that the formation of lumens is genetically pro-
grammed, lumen diameter also incorporates the input of physical
forces. Flow imposes unique signaling cues, and there is
a remarkable level of homeostatic regulation that is initiated
during development and that requires the combined coordinated
responseof all layersof thebloodvesselwall. Thedynamicnature
of EC lumen and tube formation coupled with coincident sprout-
ing events suggest additional important differences between
epitheliumandendothelium.Critical distinctions are likely to exist
in the nature of the junctional contacts between ECs compared
with those present between epithelial cells. Although it is a teleo-
logical argument at this point, one would also anticipate differen-
tial junctional regulation along the hierarchical vascular tree
within arteries, capillaries, and veins and within different tissue-
specific vascular beds. Upcoming challenges include delineating
the molecular sequence that triggers and completes lumen
formation, identifying the processes that regulate lumen size,
and understanding how the different layers of the vessel wall
crosstalk to control vessel diameter.
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